Graphite Bio, Inc.

NasdaqGM:GRPH Stock Report

Market Cap: US$190.4m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Graphite Bio Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Kim Drapkin

Chief executive officer

US$624.4k

Total compensation

CEO salary percentage32.1%
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure3.8yrs

Recent management updates

Recent updates

Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation

Sep 20
Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation

We're Hopeful That Graphite Bio (NASDAQ:GRPH) Will Use Its Cash Wisely

Jun 02
We're Hopeful That Graphite Bio (NASDAQ:GRPH) Will Use Its Cash Wisely

Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?

Feb 01
Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?

Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation

Oct 05
Here's Why We're Watching Graphite Bio's (NASDAQ:GRPH) Cash Burn Situation

Graphite Bio doses first patient with GPH101 for sickle cell disease

Aug 11

Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?

Jun 22
Will Graphite Bio (NASDAQ:GRPH) Spend Its Cash Wisely?

Graphite Bio: Selling For Much Less Than Net Cash

May 25

Graphite Bio: An Important Stock To Track In The Gene Editing Space

Nov 18

Graphite Bio (NASDAQ:GRPH) Is In A Good Position To Deliver On Growth Plans

Sep 25
Graphite Bio (NASDAQ:GRPH) Is In A Good Position To Deliver On Growth Plans

Graphite Bio: Assessing Prospects Amid Doubts Raised On Safety Of Crispr

Aug 30

CEO Compensation Analysis

How has Kim Drapkin's remuneration changed compared to Graphite Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$624kUS$201k

-US$125m

Compensation vs Market: Kim's total compensation ($USD624.39K) is below average for companies of similar size in the US market ($USD1.47M).

Compensation vs Earnings: Insufficient data to compare Kim's compensation with company performance.


CEO

Kim Drapkin (55 yo)

less than a year

Tenure

US$624,385

Compensation

Ms. Kimberlee Cobleigh Drapkin, also known as Kim, CPA, was an Independent Director of Graphite Bio, Inc. since August 03, 2023 and serves as its President, Chief Executive Officer and Principal Executive,...


Board Members

NamePositionTenureCompensationOwnership
Kimberlee Drapkin
Presidentless than a yearUS$624.39kno data
Matthew Porteus
Academic Founder & Director4yrsUS$148.40k6.06%
$ 11.5m
Perry Karsen
Independent Chairman of the Board3.8yrsUS$112.02k0.28%
$ 536.4k
Joseph Jimenez
Independent Director3.8yrsUS$84.90k0.28%
$ 529.5k
Kristen Hege
Independent Director2.9yrsUS$83.40k0%
$ 0
Jerel Davis
Independent Director4.4yrsUS$84.90k0%
$ 0
Carlo Rizzuto
Independent Director4yrsUS$83.40k0%
$ 0
Smital Shah
Independent Director2.9yrsUS$88.40k0.010%
$ 19.2k
Joanne Viney
Independent Director3yrsUS$83.40k0%
$ 0
Abraham Bassan
Independent Director3.8yrsUS$83.40k0%
$ 0

3.8yrs

Average Tenure

56yo

Average Age

Experienced Board: GRPH's board of directors are considered experienced (3.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/21 11:43
End of Day Share Price 2024/03/21 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Graphite Bio, Inc. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Konstantinos BiliourisBMO Capital Markets Equity Research
Gregory HarrisonBofA Global Research
Yun ZhongBTIG